Literature DB >> 20431214

A histopathological study of ovarian neoplasms in children in a tertiary hospital of northern Nigeria.

Abdullahi Mohammed1, S A Malami, B Calvin, K Abdullahi.   

Abstract

BACKGROUND: Information concerning the frequency and pattern of ovarian tumours in children is scant, more so in northern Nigeria. In view of this, we reviewed ovarian biopsies obtained from children in Zaria over a 25-year period.
MATERIALS AND METHODS: Ovarian tumours occurring in 48 patients of age 15 years and below were reviewed and classified using the current World Health Organization (WHO) histological classification of ovarian tumours.
RESULTS: Ovarian tumours in children accounted for 8.6% of all cases of tumours seen in all age groups over the period. Among all the malignant tumours seen in this period, 32% occurred in children, and Burkitt's lymphoma accounted for 31.2% of these. Germ cell tumours accounted for 58.0% while epithelial tumours had a frequency of 2.1%.
CONCLUSION: Burkitt's lymphoma is the most common childhood ovarian tumour in Zaria, northern Nigeria.

Entities:  

Mesh:

Year:  2010        PMID: 20431214     DOI: 10.4103/0189-6725.62848

Source DB:  PubMed          Journal:  Afr J Paediatr Surg        ISSN: 0974-5998


  3 in total

1.  Childhood ovarian neoplasms in Ibadan, South-western Nigeria.

Authors:  Mustapha Akanji Ajani; Kolawole Olanrewaju Aramide; Tinuade Adesola Ajani; Ayodeji A Salami; Clement Abu Okolo
Journal:  Niger Med J       Date:  2016 May-Jun

2.  A pathological and clinical study of 706 primary tumours of the ovary in the largest tertiary hospital in Ghana.

Authors:  Patrick Kafui Akakpo; Leonard Derkyi-Kwarteng; Richard Kwasi Gyasi; Solomom Edward Quayson; Simon Naporo; Jehoram Tei Anim
Journal:  BMC Womens Health       Date:  2017-04-17       Impact factor: 2.809

3.  Ovarian neoplasia in adolescence: a retrospective chart review of girls with neoplastic ovarian tumors in Saudi Arabia.

Authors:  Lateefa AlDakhil; Asma Aljuhaimi; Mashael AlKhattabi; Saleh Alobaid; Rafif E Mattar; Abdulaziz Alobaid
Journal:  J Ovarian Res       Date:  2022-09-16       Impact factor: 5.506

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.